Almost half of all European-registered clinical trials: in which scientists test drug treatments, interventions or therapies in humans: have breached EU rules by failing to report results, according to an analysis published on Thursday. The analysis also found that while most major pharmaceutical companies are coming close to complying with EU reporting rules for trials in people, most major academic institutes are not. European Union guidelines say that funders of clinical trials must ensure all studies entered on the EU Clinical Trials Register since 2004 have posted results there within a year of concluding. Advocates for transparency in science say enforcing the rule is necessary to ensure researchers do not bury results they consider unfavorable.

Source: Channel News Asia

Pin It on Pinterest